Jump to full article: The Arizona Republic, 2008-08-22
Author: Ken Alltucker
Intro: scientists in Arizona and elsewhere believe tobacco plants may hold the key to developing a personalized cancer vaccine as well as treatments for other diseases.
The experiments are part of a growing field of plant-based biotechnology, and the cancer treatment has gained enough traction to interest the likes of German drug giant Bayer.
"Most important is that the vaccine has been successfully used in human clinical trials," said Charles Arntzen, director of the ASU Biodesign Institute's Center for Infectious Diseases and Vaccinology.
The made-to-order vaccine has been tested in an early-stage clinical trial, and it showed an immune response in 70 percent of non-Hodgkin's lymphoma patients without harmful side effects.
Jump to full article » |